These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 1322689

  • 1. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia.
    Urbano-Ispizua A, Matutes E, Villamor N, Sierra J, Pujades A, Reverter JC, Feliu E, Cervantes F, Vives-Corrons JL, Montserrat E.
    Br J Haematol; 1992 Jun; 81(2):178-83. PubMed ID: 1322689
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G, Bruno A, Masi M, Tabilio A, Papa G.
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [Abstract] [Full Text] [Related]

  • 3. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M, Kusenda J, Babusikova O.
    Neoplasma; 2005 Mar; 52(3):211-8. PubMed ID: 15875082
    [Abstract] [Full Text] [Related]

  • 4. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).
    Seshi B, Kashyap A, Bennett JM.
    Br J Haematol; 1992 Jul; 81(3):374-7. PubMed ID: 1382546
    [Abstract] [Full Text] [Related]

  • 5. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS, Medeiros LJ, Chang KL, Brynes RK, Slovak ML, Arber DA.
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [Abstract] [Full Text] [Related]

  • 6. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
    Praxedes MK, De Oliveira LZ, Pereira Wda V, Quintana IZ, Tabak DG, De Oliveira MS.
    Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
    [Abstract] [Full Text] [Related]

  • 7. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR, Chang Y, Ruan GR, Qin YZ, Lai YY, Shi HX, Wang YZ, Li LD, Jiang B, Li JL.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87.
    Creutzig U, Harbott J, Sperling C, Ritter J, Zimmermann M, Löffler H, Riehm H, Schellong G, Ludwig WD.
    Blood; 1995 Oct 15; 86(8):3097-108. PubMed ID: 7579404
    [Abstract] [Full Text] [Related]

  • 9. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N, Musto P, D'Arena G, Melillo L, Carella AM, Petrilli MP, Sanpaolo G, Carotenuto M.
    Haematologica; 1998 May 15; 83(5):392-7. PubMed ID: 9658721
    [Abstract] [Full Text] [Related]

  • 10. Lymphoid-associated antigen expression by acute myeloid leukemia.
    Launder TM, Bray RA, Stempora L, Chenggis ML, Farhi DC.
    Am J Clin Pathol; 1996 Aug 15; 106(2):185-91. PubMed ID: 8712171
    [Abstract] [Full Text] [Related]

  • 11. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
    Jiang NG, Chen XM, Zhu HL, Zhong L, Zeng TT, Jia YQ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec 15; 18(6):1405-9. PubMed ID: 21176339
    [Abstract] [Full Text] [Related]

  • 12. Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study.
    Kuerbitz SJ, Civin CI, Krischer JP, Ravindranath Y, Steuber CP, Weinstein HJ, Winick N, Ragab AH, Gresik MV, Crist WM.
    J Clin Oncol; 1992 Sep 15; 10(9):1419-29. PubMed ID: 1517785
    [Abstract] [Full Text] [Related]

  • 13. Minimally differentiated acute myeloid leukaemia (AML-M0): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases.
    Venditti A, Del Poeta G, Stasi R, Masi M, Bruno A, Buccisano F, Cox C, Coppetelli U, Aronica G, Simone MD.
    Br J Haematol; 1994 Dec 15; 88(4):784-93. PubMed ID: 7819103
    [Abstract] [Full Text] [Related]

  • 14. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB, Zheng JE, Gu JX, Yao JX, Yang J, Liu J, Li XQ, He YL, Yu JM, Wei J, Liu ZP, Huang SA.
    Ai Zheng; 2005 Jun 15; 24(6):667-71. PubMed ID: 15946475
    [Abstract] [Full Text] [Related]

  • 15. Immunophenotyping of acute myeloid leukaemia: relevance of analysing different lineage-associated markers.
    Lo Coco F, Pasqualetti D, Lopez M, Panzini E, Gentile A, Latagliata R, Monarca B, De Rossi G.
    Blut; 1989 May 15; 58(5):235-40. PubMed ID: 2720173
    [Abstract] [Full Text] [Related]

  • 16. Acute myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A, Hrivnáková A, Babusíková O.
    Neoplasma; 1993 May 15; 40(6):341-5. PubMed ID: 8289964
    [Abstract] [Full Text] [Related]

  • 17. Value of monoclonal anti-myeloperoxidase (MPO7) for diagnosing acute leukaemia.
    Storr J, Dolan G, Coustan-Smith E, Barnett D, Reilly JT.
    J Clin Pathol; 1990 Oct 15; 43(10):847-9. PubMed ID: 1977771
    [Abstract] [Full Text] [Related]

  • 18. CD7 expression in acute myeloid leukemia.
    Del Poeta G, Stasi R, Venditti A, Cox C, Aronica G, Masi M, Bruno A, Simone MD, Buccisano F, Papa G.
    Leuk Lymphoma; 1995 Mar 15; 17(1-2):111-9. PubMed ID: 7539657
    [Abstract] [Full Text] [Related]

  • 19. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O, Mesárosová A, Koníková M, Kusenda J, Glasová M, Klobusická M.
    Neoplasma; 1993 Mar 15; 40(5):275-81. PubMed ID: 8272155
    [Abstract] [Full Text] [Related]

  • 20. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
    Lanza F, Latorraca A, Moretti S, Castagnari B, Ferrari L, Castoldi G.
    Cytometry; 1997 Jun 15; 30(3):134-44. PubMed ID: 9222099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.